| A cancer cell program promotes T cell exclusion and resistance to checkpoint blockade L Jerby-Arnon, P Shah, MS Cuoco, C Rodman, MJ Su, JC Melms, ... Cell 175 (4), 984-997. e24, 2018 | 1011 | 2018 |
| Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids RW Jenkins, AR Aref, PH Lizotte, E Ivanova, S Stinson, CW Zhou, ... Cancer discovery 8 (2), 196-215, 2018 | 433 | 2018 |
| Emergence of Multiple EGFR Extracellular Mutations during Cetuximab Treatment in Colorectal Cancer S Arena, B Bellosillo, G Siravegna, A Martínez, I Canadas, L Lazzari, ... Clinical cancer research 21 (9), 2157-2166, 2015 | 280 | 2015 |
| Tumor innate immunity primed by specific interferon-stimulated endogenous retroviruses I Cañadas, R Thummalapalli, JW Kim, S Kitajima, RW Jenkins, ... Nature medicine 24 (8), 1143-1150, 2018 | 243 | 2018 |
| 3D microfluidic ex vivo culture of organotypic tumor spheroids to model immune checkpoint blockade AR Aref, M Campisi, E Ivanova, A Portell, D Larios, BP Piel, N Mathur, ... Lab on a Chip 18 (20), 3129-3143, 2018 | 213 | 2018 |
| Increased ALK gene copy number and amplification are frequent in non-small cell lung cancer M Salido, L Pijuan, L Martínez-Avilés, AB Galván, I Cañadas, A Rovira, ... Journal of thoracic oncology 6 (1), 21-27, 2011 | 181 | 2011 |
| Targeting epithelial-to-mesenchymal transition with Met inhibitors reverts chemoresistance in small cell lung cancer I Canadas, F Rojo, Á Taus, O Arpí, M Arumí-Uría, L Pijuan, S Menéndez, ... Clinical Cancer Research 20 (4), 938-950, 2014 | 142 | 2014 |
| EZH2 inhibition activates a dsRNA–STING–interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer KL Morel, AV Sheahan, DL Burkhart, SC Baca, N Boufaied, Y Liu, X Qiu, ... Nature cancer 2 (4), 444-456, 2021 | 137 | 2021 |
| The long and short non-coding RNAs modulating EZH2 signaling in cancer S Mirzaei, MH Gholami, K Hushmandi, F Hashemi, A Zabolian, I Canadas, ... Journal of hematology & oncology 15 (1), 18, 2022 | 102 | 2022 |
| Autophagy inhibition dysregulates TBK1 signaling and promotes pancreatic inflammation S Yang, Y Imamura, RW Jenkins, I Cañadas, S Kitajima, A Aref, ... Cancer immunology research 4 (6), 520-530, 2016 | 102 | 2016 |
| Intrinsic immunogenicity of small cell lung carcinoma revealed by its cellular plasticity NR Mahadevan, EH Knelson, JO Wolff, A Vajdi, M Saigí, M Campisi, ... Cancer discovery 11 (8), 1952-1969, 2021 | 93 | 2021 |
| The first-in-class anti-EGFR antibody mixture Sym004 overcomes cetuximab resistance mediated by EGFR extracellular domain mutations in colorectal cancer FJ Sánchez-Martín, B Bellosillo, M Gelabert-Baldrich, A Dalmases, ... Clinical Cancer Research 22 (13), 3260-3267, 2016 | 69 | 2016 |
| C-MET as a new therapeutic target for the development of novel anticancer drugs I Canadas, F Rojo, M Arumí-Uría, A Rovira, J Albanell, E Arriola Clinical and Translational Oncology 12, 253-260, 2010 | 63 | 2010 |
| MET expression and copy number heterogeneity in nonsquamous non-small cell lung cancer (nsNSCLC) D Casadevall, J Gimeno, S Clavé, Á Taus, L Pijuan, M Arumí, M Lorenzo, ... Oncotarget 6 (18), 16215, 2015 | 62 | 2015 |
| MET phosphorylation predicts poor outcome in small cell lung carcinoma and its inhibition blocks HGF-induced effects in MET mutant cell lines E Arriola, I Canadas, M Arumí-Uría, M Dómine, JA Lopez-Vilariño, O Arpí, ... British journal of cancer 105 (6), 814-823, 2011 | 60 | 2011 |
| Tumor-derived cGAMP regulates activation of the vasculature M Campisi, SK Sundararaman, SE Shelton, EH Knelson, NR Mahadevan, ... Frontiers in Immunology 11, 2090, 2020 | 47 | 2020 |
| Reprogramming of the esophageal squamous carcinoma epigenome by SOX2 promotes ADAR1 dependence Z Wu, J Zhou, X Zhang, Z Zhang, Y Xie, J Liu, ZV Ho, A Panda, X Qiu, ... Nature genetics 53 (6), 881-894, 2021 | 46 | 2021 |
| High circulating hepatocyte growth factor levels associate with epithelial to mesenchymal transition and poor outcome in small cell lung cancer patients I Cañadas, Á Taus, I González, X Villanueva, J Gimeno, L Pijuan, ... Oncotarget 5 (14), 5246, 2014 | 43 | 2014 |
| Molecular and genomic determinants of response to immune checkpoint inhibition in cancer RW Jenkins, R Thummalapalli, J Carter, I Cañadas, DA Barbie Annual Review of Medicine 69, 333-347, 2018 | 42 | 2018 |
| Genetic changes in small cell lung carcinoma E Arriola, I Cañadas, M Arumí, F Rojo, A Rovira, J Albanell Clinical and Translational Oncology 10, 189-197, 2008 | 40 | 2008 |
